
Czech Researchers Discover a Molecular Switch That Controls Ribosome Production in Cells
10. 11. 2026
Scientists at the Institute of Molecular Genetics of the Czech Academy of Sciences (IMG) have uncovered a previously unknown mechanism that regulates the production of ribosomes – tiny molecular machines essential for protein synthesis. They discovered that two enzymes work together as a molecular switch to ensure that this process runs smoothly. Disrupting this mechanism also makes cells more sensitive to certain anticancer compounds, opening up new avenues for cancer research. The study was led by Libor Macůrek and his research team at the Czech Academy of Sciences in collaboration with colleagues from Charles University. The findings were published in the prestigious scientific journal Nucleic Acids Research.
Every cell in our body relies on proteins to carry out almost all its essential functions. These proteins are produced by ribosomes, tiny molecular machines assembled in a specialised region of the cell nucleus called the nucleolus.
What makes the nucleolus remarkable is that it has no surrounding membrane separating it from the rest of the nucleus. Instead, its components are held together through a process known as condensation, somewhat like tiny droplets of oil forming in water. This allows the nucleolus to continuously reorganise and adapt to the changing needs of the cell.
A protein called TCOF1 plays a key role in organising the nucleolus. Its importance is highlighted by the fact that inherited mutations in the gene encoding TCOF1 cause Treacher Collins syndrome, a rare genetic disorder that affects facial development. However, exactly how TCOF1 activity is regulated has remained unclear.
Two Enzymes Acting as a Molecular Switch
The research team led by Libor Macůrek has now discovered that TCOF1 is regulated by two enzymes with opposing functions. Their cooperation resembles a control mechanism that keeps a production line running smoothly.
The first enzyme, CK2, attaches small chemical tags known as phosphate groups to TCOF1. These modifications help the proteins organise themselves correctly and allow TCOF1 to bind RNA polymerase I – an enzyme that transcribes genetic information into ribosomal RNA, one of the essential building blocks of ribosomes.
For this process to continue, RNA polymerase I must eventually be released and become available for another cycle. This is where the second enzyme, PPM1D, comes into play. It removes the phosphate groups, likely facilitating another round of transcription. Together, the two enzymes act as a molecular switch, enabling the repeated recruitment and release of the molecules needed to produce ribosomal RNA.
When this mechanism fails, the internal organisation of the nucleolus is disrupted. Using electron microscopy, the researchers observed that cells lacking PPM1D had significantly enlarged nucleoli with a disorganised internal structure. At the same time, the production of ribosomal RNA was reduced.
The study also revealed an intriguing evolutionary connection. The ability of PPM1D to enter the nucleolus appears in tetrapods – the evolutionary group that includes amphibians, reptiles, birds and mammals – at approximately the same stage when the nucleolus developed a more complex internal organisation. Much like modernising a factory, both its machinery and its control systems may have evolved together.
“This shows that the cellular structure and its regulator evolved together,” explains Libor Macůrek, head of the Cancer Cell Biology research group at the Institute of Molecular Genetics of the Czech Academy of Sciences.
What Does This Discovery Mean for Cancer Research?
Cancer cells require large amounts of proteins to support their rapid growth and are therefore highly dependent on ribosome production. Compounds that disrupt this process by blocking RNA polymerase I are already being investigated in clinical trials.
The researchers analysed data from hundreds of cancer cell lines available in public databases and identified an interesting connection: cells that depend on the PPM1D enzyme also tend to be sensitive to compounds that inhibit RNA polymerase I.
In subsequent laboratory experiments, they found that blocking PPM1D activity increased cellular sensitivity to two such compounds, CX-5461 and actinomycin D. This effect was also observed in cells lacking functional p53, a protein that normally helps protect the body against cancer development.
“So far, these experiments have been carried out on human cells under laboratory conditions, and further research will be needed to determine whether combining PPM1D and RNA polymerase I inhibitors could benefit patients with cancer,” adds Libor Macůrek.
Read the press release on the IMG website.
Publication
Natalie Palkova, Matous Palek, Marketa Brodinova, Zuzana Chalupova, Radka Storchova, Jana Jasprova, Pavel Talacko, Dusan Cmarko, Libor Macurek: Dynamic phosphorylation of TCOF1 controlled by CK2 and PPM1D regulates nucleolar condensation and RNA polymerase I activity. Nucleic Acids Res 2026. [doi]
Read also
- Stone and water determined human settlement of the desert
- Urine and blood tests could help detect a life-threatening fungal infection
- Can we entrust our health to artificial intelligence?
- Scientists uncover a key mechanism of adrenal damage in Addison’s disease
- Prestigious EPS Europhysics Prize Awarded to Czech Physicists
- Space chirping has its order. Czech scientists have revealed when and where it sounds.
- Discovery by an NPI-led research team could contribute to safer wind turbine operation
- Unassuming Start–Stop “Gates” Regulate Protein Production in Cells
- Archaeologists search for traces of the persecution of German civilians in Africa
- Researchers Correct Genetic Defect Associated with Retinitis Pigmentosa Using Modified RNA Molecules
Contacts for Media
Markéta Růžičková
Public Relations Manager
+420 777 970 812
Eliška Zvolánková
+420 739 535 007
Lucie Peřinová
+420 777 728 090
Eliška Hadravová
+420 737 349 484